Hospitalisation for adverse events related to drug therapy: Incidence, avoidability and costs

Medical Journal of Australia

Volumn 164, Issue 11, 1996, Pages 659-662

  Dartnell, Jonathan G A ^a,b   Anderson, Robert P ^a,c   Chohan, Veronica ^a,c   Galbraith, Kirsten J ^a,b   Lyon, Moira E H ^a,b   Nestor, Peter J ^a,c   Moulds, Robert F W ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b Dept Clin Pharmacol Therapeut ^*

^c General Medical Service

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PRESCRIPTION;

EID: 0029984025     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb122235.x     Document Type: Article

References (14)

1. Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27: 832-840.
2. Larmour I, Dolphin RD, Baxter H, et al. A prospective study of hospital admissions due to drug reactions. Aust J Hosp Pharm 1991; 21: 90-95.
3. National Health Strategy. Pharmaceutical drug use problems. In: Issues in pharmaceutical drug use in Australia, Issues Paper No 4. Canberra: Department of Health, Housing and Community Services, June 1992: 33-41.
4. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP Ann Pharmacother 1990; 24: 1093-1097.
5. Antibiotic Guidelines Sub-Committee, Victorian Drug Usage Advisory Committee. Antibiotic guidelines. 8th ed. Melbourne: Victorian Medical Postgraduate Foundation Inc., Therapeutics Committee, 1994.
6. International drug monitoring: the role of the hospital - a WHO report. Drug Intell Clin Pharm 1970; 4: 101-110.
7. Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234: 1236-1241.
8. Klein L, Klein M, Sturm H, et al. The frequency of adverse drug reactions as dependent on age, sex and duration of hospitalisation. Int J Clin Pharmacol 1976; 13: 187-195.
9. Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med 1974; 134: 219-223.
10. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90.
11. Col N, Fanale JE, Kronholme R The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-845.
12. Cramer JA. Relationship between medication compliance and medical outcomes. Am J Health Syst Pharm 1995; 52 (Suppl 3): 27-29.
13. Ioannides-Demos LL. Reducing hospital admissions related to adverse drug reactions: what is the GPs role? Curr Therapeutics 1994; 35: 13-17.
14. Pearson TF, Pittman DG, Longley JM, et al. Factors associated with preventable adverse drug reactions. Am J Hosp Pharm 1994; 51: 2268-2272.